Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Anna
Anna graduated from Harvard University with a BA in English and a minor in Linguistics and Language Theory. While at Harvard, she was a curriculum editor for the Mamelodi Initiative in South Africa.
Kate
Kate earned her BA in Public Policy from Stanford, and then completed a year of service with City Year San Jose before joining The Bridgespan Group, a nonprofit consulting organization. She now teaches English in Madrid, Spain.